Health·2,840 stories
New Cell Reports research from the Medical University of South Carolina shows that EPA, a major omega‑3 in fish oil, can hinder blood‑vessel repair and promote harmful protein buildup after repeated m
A KAIST team uncovered that graphene oxide selectively binds to bacterial POPG, destroying superbugs while sparing human cells. In nanofiber form it kills drug‑resistant bacteria, accelerates wound he
A growing body of anecdotal reports shows that AI chatbots can reinforce and intensify delusional thinking—spanning grandiose, god‑like, and romantic attachments—creating a new mental‑health risk dubb
Harvard researchers have uncovered a molecular bridge between a gut bacterium, Morganella morganii, and depression. When the microbe metabolizes the pollutant diethanolamine, it creates a compound tha
Nancy Cox, the CDC’s long‑time influenza chief who expanded the division from a 14‑person unit to a global network of over 100 experts, died at 77 from glioblastoma. Colleagues praised her scientific
Thomas Goetz’s new podcast 'Drug Story', hosted on STAT’s First Opinion platform, uses a three‑act format inspired by 'This American Life' to unpack the cultural, economic and medical narratives behin
A new study of 1,300 UK climate activists shows that criminalising non‑violent protest—through arrests, fines and long prison terms—actually strengthens resolve and may push demonstrators toward cover
Space scientist Dame Dr Maggie Aderin, formally diagnosed with dyslexia only last year, reframes her experience as a gift shaped by 'dyslexic thinking' — empathy, lateral thinking, and resilience — co
After two years of waiting, a young Sumatran orangutan finally crossed a newly built canopy bridge over the Lagan‑Pagindar road, proving that infrastructure can coexist with wildlife. The achievement,
The FDA is fast-tracking psychedelic treatments from Compass Pathways, Usona Institute, and Transcend Therapeutics, granting priority review vouchers to boost access to psilocybin and MDMA-like drugs
NIST researchers spent a decade building a record-precision measurement of the gravitational constant, obtaining a value that narrows but doesn't fully close the long-standing scatter in big G experim
Eli Lilly is buying cash‑strapped cell‑therapy developer Kelonia Therapeutics for $3.2 billion, a deal that could double with milestone payments. Partner Bryan Roberts of Venrock explains how the star
Tenpoint Therapeutics has hired Stephen Lane as its new chief medical officer, bringing his Alcon experience and leadership of the Holland Foundation for Sight Restoration to the company. The appointm
President Trump’s drug policy overhaul moves medical marijuana to Schedule III and opens doors for psychedelics research, while CMS and FDA roll out a fast‑track Medicare pathway for breakthrough devi
President Trump closed the White House’s 17‑deal pharma pricing push with Regeneron, locking in a $27 billion U.S. drug‑development investment and a $225 price for Praluent on TrumpRx. At the same tim
Amid ongoing legal battles for the Trump administration, biotech headlines dominate: Sanofi’s multiple sclerosis therapy, turned down by the FDA, earned a positive recommendation from European regulat
A nine-month trial of personalized treatment plans for 73 people with mild cognitive impairment or early-stage dementia found that participants who received bespoke medical and lifestyle interventions
Physicists James Hefford and Matt Wilson have outlined a post‑quantum framework called QBox, where a hyperdecoherence process generates ordinary quantum mechanics while permitting causal indefinitenes
After a string of costly anti‑aging flops—from resveratrol’s $720 million demise at GSK to failed senolytics—researchers are finally testing a new approach: transient expression of Yamanaka factors to
A newly confirmed mass grave in Jerash, Jordan, shows that hundreds of people died within days during the Plague of Justinian, offering direct archaeological and genetic evidence of the pandemic’s rap
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.